Showing results (1291-1300 of 10,440) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|January 25, 2003
Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observationRegina Hofmann-Lehmann, Josef Vlasak, Alison L Williams, et al.AIDS (London, England)|January 25, 2003
Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virusMichael J Cannon, Sheila C Dollard, Jodi B Black, et al.AIDS (London, England)|January 25, 2003
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patientsPaola Costa, Stefano Rusconi, Manuela Fogli, et al.AIDS (London, England)|January 25, 2003
Individualizing salvage regimens: the inhibitory quotient (Ctrough/IC50) as predictor of virological responseJose L Casado, Ana Moreno, Raquel Sabido, et al.AIDS (London, England)|September 28, 2002
No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapyZabrina L Brumme, Keith J Chan, Winnie W Dong, et al.AIDS (London, England)|May 24, 2001
Quantitative and qualitative abnormalities in HIV-1-specific T cellsN Watanabe, M Tomizawa, A Tachikawa-Kawana, et al.AIDS (London, England)|May 24, 2001
Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapyM John, C B Moore, I R James, et al.AIDS (London, England)|May 24, 2001
HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative studyAIDS (London, England)|March 28, 2003
Simple markers for initiating antiretroviral therapy among HIV-infected EthiopiansYared Mekonnen, Nicole H Dukers, Eduard Sanders, et al.AIDS (London, England)|March 28, 2003
Phenotypic susceptibility and virological outcome in nucleoside-experienced patients receiving three or four antiretroviral drugsDavid A Katzenstein, Ronald J Bosch, Nicholas Hellmann, et al.Pageof 1,044